Angiotensin II Antagonism and the Heart: Valsartan in Left Ventricular Hypertrophy | Citedby Results | Cardiology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Angiotensin II Antagonism and the Heart: Valsartan in Left Ventricular Hypertrophy

Cardiology (1999) 91 (Suppl. 1): 3–7.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Effects of the combinations of amlodipine/valsartan versus losartan/hydrochlorothiazide on left ventricular hypertrophy as determined with magnetic resonance imaging in patients with hypertension

Oliver Bruder
Christoph J. Jensen
Michael Bell
Reinhard Rummel
Guenter Boehm
Sven Klebs
Christian Sieder
Jochen Senges

Journal of Drug Assessment (2012) 1 (1): 1.

Cardiac MRI: accuracy of simultaneous measurement of left and right ventricular parameters using three different sequences

Juha W. Koskenvuo
Henna Karra
Jaakko Lehtinen
Pekka Niemi
Jussi Pärkkä
Juhani Knuuti
Jaakko J. Hartiala

Clinical Physiology and Functional Imaging (2007) 27 (6): 385.

Effect of Dominant-Negative Epidermal Growth Factor Receptors on Cardiomyocyte Hypertrophy

HSIU-WEN CHAN
ANNA JENKINS
LUISA PIPOLO
ROSS D. HANNAN
WALTER G. THOMAS
NICOLA J. SMITH

Journal of Receptors and Signal Transduction (2006) 26 (5-6): 659.

Left Ventricular Hypertrophy – the Problem and Possible Solutions

P Gosse

Journal of International Medical Research (2005) 33 (1_suppl): 3A.

Role of Angiotensin II AT1 Receptor Blockers in the Treatment of Arterial Hypertension

Freddy Contreras
Mar??a Antonia de la Parte
Julio Cabrera
Nestor Ospino
Zafar H. Israili
Manuel Velasco

American Journal of Therapeutics (2003) 10 (6): 401.

TrueFISP: Assessment of accuracy for measurement of left ventricular mass in an animal model

David S. Fieno
Wyatt C. Jaffe
Orlando P. Simonetti
Robert M. Judd
J. Paul Finn

Journal of Magnetic Resonance Imaging (2002) 15 (5): 526.

Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs

K O Stumpe
M Ludwig

Journal of Human Hypertension (2002) 16 (S2): S24.

A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged ≥65 years with mild to moderate hypertension

Yves Lacourcière

Clinical Therapeutics (2000) 22 (10): 1213.